TYMS and cancer: The same genetic pattern was previously described in 20 leukemic children who were receiving the Children’s Cancer Group-1891 protocol; 7 (35%) of these patients relapsed and the TS 3R/4R genotype was associated with significantly greater relapse risk in that study [23].